BASF/Takeda
This article was originally published in The Tan Sheet
Executive Summary
FTC has no objection to merger of BASF and Takeda Chemical Industries bulk vitamin businesses. The deal, announced in July, awaits foreign antitrust agency approvals. The firms' combined operations would hold a 30% market share of the worldwide vitamin market. The planned merger is the beginning of BASF's [Euro]600 mil. (about $540 mil.) investment to expand capacity for cost-efficient bulk vitamin production (1"The Tan Sheet" Aug. 7, p. 9)
You may also be interested in...
Roche Vitamins Divestiture Will Not Occur Piecemeal, Chairman Says
Hoffman-La Roche's Vitamins & Fine Chemicals division could be sold to a raw material supplier without a substantial presence in vitamins or to a large food manufacturer
Roche Vitamins Divestiture Will Not Occur Piecemeal, Chairman Says
Hoffman-La Roche's Vitamins & Fine Chemicals division could be sold to a raw material supplier without a substantial presence in vitamins or to a large food manufacturer
Roche Vitamins Divestiture Will Not Occur Piecemeal, Chairman Says
Hoffman-La Roche's Vitamins & Fine Chemicals division could be sold to a raw material supplier without a substantial presence in vitamins or to a large food manufacturer